{"text": "TITLE:\n      Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)\nSUMMARY:\n      This is a study to evaluate the safety, tolerability, and potential effects of Anatabloc\n      dietary supplementation on antithyroid autoantibodies, thyroid structure, and thyroid\n      function in subjects with autoimmune thyroiditis.\nDETAILED DESCRIPTION:\n      This is a 5-visit, 12-week, double-blind, randomized, placebo-controlled, parallel-group\n      study.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  adults 18-70 years of age\n          -  having positive antibodies against thyroid peroxidase\n          -  having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis\n        Exclusion Criteria:\n          -  having evidence of end-stage thyroiditis\n          -  being a current smoker or smokeless tobacco user\n          -  be taking systemic glucocorticoids, interferon-alpha, anti-CD20 antibody, or\n             anti-CTLA-4 antibody\n          -  be taking any medication for treatment of autoimmune thyroiditis other than\n             L-thyroxine or equivalent\n", "cuis": "C0242297 C0242296 C1947943 C0443146 C0199176 C0040132 C0040134 C1328956 C2718080 C1552616 C1706244 C0947630 C0220825 C2222792 C0242297 C0561937 C3833453 C3250220 C1272321 C0040132 C0040134 C2228489 C0076638 C0117002 C0677607 C0920350 C0271813 C0031843 C1705273 C0678257 C0033080 C1521941 C0032042 C0456909 C0180112 C2911690 C1552839 C0947630 C0243161 C0013893 C0243161 C3495458 C0813154 C1318719 C0040132 C0040134 C2228489 C0076638 C0117002 C0518505 C0522772 C1548746 C1514241 C0677607 C0011900 C0945731 C0551521 C0552426 C0560182 C0686906 C0679838 C0518505 C0522772 C1548746 C0041618 C2183261 C0243161 C0040147 C1300072 C0518505 C0522772 C1548746 C3241966 C3173209 C3853727 C0841002 C1698618 C0040335 C1971295 C1450035 C0002199 C0172511 C0756832 C3540777 C3540778 C0021027 C0201278 C0021027 C0201278 C0677607 C0920350 C0271813 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0079691 C0040165 ", "concepts": "Supplementation, Food Supplementation, Supplement, Autoimmune, Prevention, Thyroids, Thyroid, eHealth, mHealth summary, summary study, Evaluate, OT potential dietary supplementation, Sodium - dietary supplementation, autoantibodies, csf autoantibodies, autoantibodies test, thyroids, thyroid, thyroid, thyroidin, Euthyroid autoimmune thyroiditides, Autoimmune thyroiditis, NOS, Fibrous autoimmune thyroiditis, function, Function description, prescription, prescription placebo, blind, controllers, Controlled, groups study criteria, Eligibility Criteria antibodies, Antibodies, peroxidase, thyroids, thyroid, thyroid, thyroidin, Euthyroid, shaving, shaving, Shaving, Positive Hashimoto's thyroiditis, diagnosis, Diagnosis, ED diagnosis, ED diagnosis, no diagnosis, No diagnosis, Misdiagnosis, shaving, shaving, Shaving, sonography, sonography Criteria thyroiditis, stage, shaving, shaving, Shaving Current smoker, Current smoker, tobacco user, Tobacco use, Ex-tobacco user, Tobacco use, Non-tobacco user, Smokeless interferon-alpha, interferon-alpha 8, interferon-alpha B-D, Glucocorticoids, Glucocorticoids, Antibody, Antibody Antibody, Antibody autoimmune thyroiditides, Autoimmune thyroiditis, NOS, Fibrous autoimmune thyroiditis, Medications, medication:, medications:, Premedication, IV medication, Medications, Medications, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment L-thyroxine, thyroxine "}
